Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.70
-0.10 (-0.93%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Beta Bionics Revenue
In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth. Beta Bionics had revenue of $32.12M in the quarter ending December 31, 2025, with 57.15% growth.
Revenue (ttm)
$100.25M
Revenue Growth
+53.94%
P/S Ratio
4.74
Revenue / Employee
$237,000
Employees
423
Market Cap
474.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 3 days ago - SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX) - PRNewsWire
- 8 days ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - PRNewsWire
- 14 days ago - BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - Business Wire
- 15 days ago - INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - PRNewsWire
- 17 days ago - BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - GlobeNewsWire
- 21 days ago - BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - PRNewsWire
- 4 weeks ago - Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 weeks ago - Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call Transcript - Seeking Alpha